Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rangering i aksjer #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aksjekurs
$1.05
Sist synkronisert: 2026-08-19
Markedsverdi
$25.12M
Endring (1 dag)
0.00%
Endring (1 år)
-86.33%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Kategori

Aksjeprishistorikk for Actuate Therapeutics Inc (ACTU)
Høyeste sluttskurs: $1.04 den 2026-08-01

Laveste sluttskurs: $8.39 den 2024-08-01
Aksjeprishistorikk for Actuate Therapeutics Inc fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -36.60%
2025 -14.02%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.05 -14.77%
AU
$753.28 5.84%
CH